Midkine inhibitors: application of a simple assay procedure to screening of inhibitory compounds
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in International Archives of Medicine
- Vol. 3 (1) , 12
Abstract
Midkine is a heparin-binding cytokine and is involved in etiology of various diseases. Thus, midkine inhibitors are expected to be helpful in treatment of many diseases.Keywords
This publication has 31 references indexed in Scilit:
- The growth factor midkine regulates the renin-angiotensin system in miceJournal of Clinical Investigation, 2009
- Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell populationProceedings of the National Academy of Sciences, 2008
- Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein graftsJournal of Vascular Surgery, 2006
- Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenograftsCancer, 2006
- Growth Factor Midkine Is Involved in the Pathogenesis of Diabetic NephropathyThe American Journal of Pathology, 2006
- Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusionKidney International, 2005
- Midkine and Pleiotrophin: Two Related Proteins Involved in Development, Survival, Inflammation and TumorigenesisThe Journal of Biochemistry, 2002
- Crystal Structure of the Extracellular Segment of Integrin αVβ3Science, 2001
- Neointima formation in a restenosis model is suppressed in midkine-deficient miceJournal of Clinical Investigation, 2000